PCNA and cancer: We then examined the potential of identified PCNA-binding NKp44-derived peptides, conjugated to cell-penetrating moieties, to (i) inhibit cancer cell proliferation or induce apoptosis in vitro and (ii) mediate tumor growth arrest in vivo, in several mouse and human cancer cell lines.